Cleveland Clinic’s recently launched laparoscopic living donor hepatectomy for liver transplant program has rapidly progressed to become the nation’s most active provider. A new report reviews the program’s progress and explains the steps necessary for success.
Elevated levels of liver enzymes appear to be a significant risk factor for more severe outcomes in COVID-19 patients, according to a recent summary of findings from Cleveland Clinic Journal of Medicine.
A team of over 40 caregivers used apheresis as a bridge to transplant for a patient with COVID-19 and liver failure.
Findings from Cleveland Clinic’s experience can inform other transplant centers of relative costs and aid in decision-making regarding referral of patients with comorbidities like hepatopulmonary syndrome.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
Cleveland Clinic has developed a protocol centered on housing transplant patients and donors in designated COVID-free units.
Cleveland Clinic opened the Medical Intensive Liver Unit in the summer of 2018, one of few in the U.S. Critical care physicians, Hassan Khouli, MD and Aanchal Kapoor, MD discuss the program and share promising outcomes data on transplant-free survival for patients with cirrhosis.
World-renowned transplant surgeon David Kwon, MD, recently joined Cleveland Clinic’s Digestive Disease & Surgery Institute as Director of Laparoscopic Liver Surgery. He and Koji Hashimoto, MD, PhD, Director of Living Donor Liver Transplantation, discuss what Dr. Kwon’s arrival means for Cleveland Clinic’s LDLT program.
A 65-year-old female with PBC and a 54-year-old male with hepatitis C-related cirrhosis and HCC benefit from simultaneous liver transplants from one deceased donor.
Cleveland Clinic surgeons used a new transplant protocol to treat a patient with liver metastases from colorectal cancer for the first time in the U.S. Learn how this protocol could improve patient outcomes.
This case of living donor liver transplantation using a small left lobe graft allowed us to treat a patient with severe portal hypertension, avoiding a crisis due to the shortage of available donor organs.